CTOs on the Move

Illumina

www.illumina.com

 
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.illumina.com
  • 5200 Illumina Way
    San Diego, CA USA 92122
  • Phone: 858.202.4500

Executives

Name Title Contact Details
Steven Barnard
Vice President and Chief Technology Officer Profile
Carissa Rollins
Chief Information Officer Profile
Jason Banthrum
Assoc Director, Application Security and Compliance Profile
Alex Aravanis
Chief Technology Officer and Head of Research and Product Development Profile
Alex Aravanis
Chief Technology Officer Profile

Similar Companies

Id Labs Inc

Id Labs Inc is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dyne Therapeutics

Dyne was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.

bioMASON

We build with carbon the same way nature does. Our biocement® materials are healthier for us and the Planet.

Project Farma (PF)

Project Farma is a patient-focused global leader in advancing technical operations from ideation through commercialization with a proven track record of planning, building, and maintaining manufacturing facilities, capital expansions, and technical operations for complex biologics and novel modalities. We provide end-to-end services for the entire manufacturing lifecycle for pharmaceutical and biotech companies, universities, hospitals, and government agencies. Project Farma has executed 100+ facility builds, retrofits and expansions, managed 400+ large scale capital projects, industrialized 10+ commercial cell, gene, and novel therapies, and managed $6B+ in technical operations capital investments. One of our core values is giving back. Volunteering at hospitals, supporting life science related fundraisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, not only do we raise awareness of many life-threatening diseases, but we also bring our team and our clients team closer to the actual patients and families that will be impacted by our work. Project Farma is a PerkinElmer company. (https://www.projectfarma.com/)